EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces antitumor immunity

Tony Yao, Rita E Chen, Melissa Yamada, J Russell Moore, Marissa Jimenez, Tammy Huang, Lynn Cornelius, George Ansstas, Naresha Saligrama, David Y Chen

Journal of Clinical Investigation · 16.11.2026 · 136 (22)

DOI: 10.1172/jci211137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, erschienen am 16.11.2026. Verfasst von Tony Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine. Hauptthemen laut MEDLINE: Melanoma, GTP Phosphohydrolases, Membrane Proteins, Skin Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaGTP PhosphohydrolasesMembrane ProteinsSkin NeoplasmsMutationBenzimidazolesBiological ProductsHerpesvirus 1, HumanOncolytic VirotherapyHumansAnimalsMice

Stichwörter der Autor:innen

Cancer immunotherapyDermatologyImmunologyMelanomaOncologySkin cancer

Substanzen

GTP PhosphohydrolasesMembrane ProteinsNRAS protein, humanbinimetinibtalimogene laherparepvecBenzimidazolesBiological Products

Autor:innen und Institutionen

  • Department of Medicine.
  • Division of Dermatology.
  • Department of Neurology.
  • Division of Oncology, and.
  • Department of Pathology and Immunology, Washington University, St. Louis, Missouri, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Yao, T., Chen, R. E., Yamada, M., Moore, J. R., Jimenez, M., Huang, T., Cornelius, L., Ansstas, G., Saligrama, N., & Chen, D. Y. (2026). Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces anti-tumor immunity. Journal of Clinical Investigation. https://doi.org/10.1172/jci211137

Vancouver

Yao T, Chen RE, Yamada M, Moore JR, Jimenez M, Huang T, et al. Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces anti-tumor immunity. Journal of Clinical Investigation. 2026. doi:10.1172/jci211137

BibTeX
@article{Yao2026,
  author = {Yao, Tony and Chen, Rita E and Yamada, Melissa and Moore, J Russell and Jimenez, Marissa and Huang, Tammy and Cornelius, Lynn and Ansstas, George and Saligrama, Naresha and Chen, David Y},
  title = {Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces anti-tumor immunity},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci211137}
}
Kostenlos starten →